Skip to main content
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,300.80
-48.15 (-3.57%)
Feb 21, 2025, 3:29 PM IST

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 33.88B INR in the quarter ending December 31, 2024, with 35.14% growth. This brings the company's revenue in the last twelve months to 139.61B, up 6.10% year-over-year. In the fiscal year ending March 31, 2024, Glenmark Pharmaceuticals had annual revenue of 126.45B with 8.49% growth.

Revenue (ttm)
139.61B
Revenue Growth
+6.10%
P/S Ratio
2.63
Revenue / Employee
9.31M
Employees
14,989
Market Cap
367.07B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020106.57B7.92B8.03%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 516.03B
Divi's Laboratories 90.78B
Cipla 267.20B
Mankind Pharma 116.41B
Apollo Hospitals Enterprise 211.46B
Zydus Lifesciences 222.47B
Aurobindo Pharma 309.22B
Alkem Laboratories 127.57B
Revenue Rankings

Glenmark Pharmaceuticals News

More News